Latest filing published 12 Aug 2011 for Elevance Health, Inc., €4,188.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -8.7%Entry US$62.29 · Close at T+365 US$56.89
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brian A. Sassi: trading record in brief
Brian A. Sassi discloses dealings in Elevance Health, Inc. to SEC (Form 4). Over a trading history stretching from 6 February 2008 to 7 June 2011, the count stands at 24 filings.
On the open market, the record shows 2 purchases worth €10k and 3 sales worth €4.8M. The net balance comes to €4.8M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 16 share grants and 2 option exercises. Since January 2011: 2 purchases and 2 sales on the market.
Most recently, on 12 August 2011, the filings show an open-market purchase worth €4,188 in Elevance Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian A. Sassi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$56.08Common StockSEC:0001127602-11-023500:0Canonical exit: 21 Dec 2010 (T+90)
- 144 shares@ US$57.30Common StockSEC:0001127602-11-023500:1Canonical exit: 2 Mar 2011 (T+90)
- 200 shares@ US$67.50Common StockSEC:0001127602-11-023500:2
- 57,000 shares@ US$30.10Common StockSEC:0001127602-11-015278:0
- 71,904 shares@ US$77.16Common StockSEC:0001127602-11-015278:1
- 2,479 shares@ US$65.98Common StockSEC:0001127602-11-008751:0
- 8,048 shares0Common StockSEC:0001127602-11-008751:1
- 6,442 shares@ US$66.81Common StockSEC:0001127602-11-008751:2
- 15,107 shares0Common StockSEC:0001127602-11-003894:0
- 26,554 shares0Common StockSEC:0001127602-10-029661:0
- 258 shares@ US$62.06Common StockSEC:0001127602-10-007246:0
- 10,071 shares0Common StockSEC:0001127602-10-007246:1
- 6,974 shares@ US$61.90Common StockSEC:0001127602-10-007246:2
- 26,137 shares0Common StockSEC:0001127602-10-003644:0
- 19,226 shares@ US$30.10Common StockSEC:0001156039-09-000137:0
- 26,361 shares@ US$56.81Common StockSEC:0001156039-09-000137:1
- 1,788 shares@ US$47.61Common StockSEC:0001156039-09-000125:0
- 594 shares@ US$30.10Common StockSEC:0001156039-09-000037:0
- 27,686 shares0Common StockSEC:0001156039-09-000037:1
- 1,788 shares@ US$39.75Common StockSEC:0001156039-08-000150:0
- 397 shares@ US$46.20Common StockSEC:0001156039-08-000076:0
- 5,694.78 shares@ US$47.46Common StockSEC:0001156039-08-000052:0
- 586 shares@ US$70.80Common StockSEC:0001156039-08-000045:0
- 2,103 shares0Common StockSEC:0001156039-08-000016:0
24 of 24 declarations
